Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of Using Epicall for Monitoring Pre-seizure Biomarkers

NCT01436695 is registered in ClinicalTrials.gov with Epicall LTD as lead sponsor.

NCT NCT01436695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01436695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of Using Epicall for Monitoring Pre-seizure Biomarkers
Lead sponsor
Epicall LTD
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2011
Completion date
Not reported
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

seizure